Načítá se...
Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients
INTRODUCTION: Fractalkine is a chemokine implicated as a mediator in a variety of inflammatory conditions. Knowledge of fractalkine release in patients presenting with infection to the Intensive Care Unit (ICU) is highly limited. The primary objective of this study was to establish whether plasma fr...
Uloženo v:
| Vydáno v: | Crit Care |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4658804/ https://ncbi.nlm.nih.gov/pubmed/26603530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-015-1125-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|